Catharina Müller‐Thomas

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients

Stefanie Jilg, Veronika Reidel, Catharina Müller‐Thomas et al. · Leukemia · 2015 · 103 citations

Progenitor Cells, Hematological Malignancy, Medicine +11

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

Sophie Park, Jean-François Hamel, Andréa Toma et al. · Journal of Clinical Oncology · 2017 · 97 citations · Full text

Hematological Malignancy, Erythropoiesis-stimulating Agents, Oncology +14

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia

Peter Herhaus, Stefan Habringer, Kathrin Philipp‐Abbrederis et al. · Haematologica · 2016 · 65 citations · Full text

Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis

Catharina Wenk, Anne-Kathrin Garz, Sonja Grath et al. · Blood Advances · 2018 · 41 citations · Full text

Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose

Stefanie Jilg, Richard Hauch, Johanna Kauschinger et al. · Experimental Hematology and Oncology · 2019 · 40 citations · Full text